BioCentury
ARTICLE | Politics, Policy & Law

2020 in Washington: another shot at drug pricing legislation, user fees and 21st Century Cures 2.0

Congress and U.S. voters could make decisions in 2020 that fundamentally reshape biopharma strategies

January 10, 2020 11:11 PM UTC

The year ahead in Washington will start with an attempt to find middle ground on restructuring the way Medicare pays for medicines, and will end with politicians making plans to implement mandates to control drug prices. In between and out of the limelight, reforms will be crafted that are intended to bring the regulation of diagnostics into the 21st century and pave paths to the integration of digital technologies into routine medical care.

Drug pricing policies that will be debated in congressional and presidential elections could shape for a generation how science is turned into medicines and how American patients access therapies. ...